Vilnius-based Oxylabs raised €113.6m led by Warburg Pincus at a €3.1bn valuation, ending an 11-year bootstrapped streak to become Lithuania’s second most valuable private company. Yann LeCun is also in talks to raise Extelligence Invest, a new €200m VC fund backing AI, data infrastructure, healthcare, robotics and deeptech startups.
Let’s dive in.
💰 Funding rounds
Vilnius-based Oxylabs secured €113.6m from Warburg Pincus at a €3.1bn valuation, ending its bootstrapped streak after 11 years and becoming Lithuania’s second most valuable private company with over €305m ARR. Read more here.
Paris-based Aria raised €7m Series A extension and launched a €240m debt facility to tackle Europe’s late-payment crisis, powering invoice financing across 70 of Europe’s largest B2B marketplaces. Read more here.
Paris-based En Carta Diagnostics raised €5m to scale at-home molecular tests for Lyme disease and STIs, combining laboratory PCR accuracy with rapid test simplicity without requiring laboratory infrastructure. Read more here.
📣 Fund news
Yann LeCun is in talks to raise Extelligence Invest, a new €200m VC fund to back AI, data infrastructure, healthcare, robotics and deeptech startups. Read more here.
🤝 M&A
Bassecourt-based Efteor and La Chaux-de-Fonds-based Télôs Watch got acquired by Vam Investments alongside established companies Le Composant and Henri Robert, marking the official launch of Groupe Chaumont. Read more here.
Subscribe to the weekly edition for the highlights here.